SuperworthCME CME
- Market cap
- $109.9B
- PE
- 25.9×
- 10y median 26.2×
- Forward PE
- 24.5×
- 10y median 24.6×
- Price to sales
- 16.2×
- EV/EBIT
- 24.3×
- Revenue, 12 months
- $6.8B
- +5% on a year ago
- Net margin
- 63.9%
- Free cash flow yield
- 3.8%
CME trades at 25.9× trailing earnings, near its ten-year median. Revenue was $6.8B over the last twelve months, up 5% on a year earlier with a 64% net margin.
Charts
Financials
| Income statement | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $1.3B+9% | $1.4B+19% | $1.5B+3% | $1.5B+13% | $1.6B+18% | $1.5B+6% | $1.6B+10% | $1.7B+10% | $1.5B−3% | $1.6B+8% | $1.9B+15% | $1.7B+1% | |
| $820.2M+11% | $863.2M+29% | $959.6M+5% | $1B+19% | $1B+25% | $947.1M+10% | $1.1B+16% | $1.1B+13% | $972.6M−5% | $1B+8% | $1.3B+18% | $1.1B−2% | |
| Interest expense | $39.6M−2% | $39.7M−1% | $39.9M+0% | $40.1M−0% | $40.2M+2% | $40.7M+3% | $41.7M+5% | $44M+10% | $44M+10% | $43.7M+7% | $43.6M+5% | $43.6M−1% |
| Pre-tax income | $974.3M+11% | $1B+22% | $1.1B−4% | $1.2B+14% | $1.2B+21% | $1.1B+9% | $1.2B+12% | $1.3B+15% | $1.2B+0% | $1.6B+44% | $1.5B+21% | $1.3B−0% |
| $224.1M+12% | $191.4M+1% | $258.2M−6% | $271.3M+14% | $264.1M+18% | $222M+16% | $288.6M+12% | $305.2M+13% | $269M+2% | $395.5M+78% | $356.6M+24% | $285.9M−6% | |
| Net income | $740.8M+10% | $844.9M+27% | $844.4M−3% | $872.1M+14% | $901.3M+22% | $908M+8% | $944.2M+12% | $1B+18% | $896.6M−1% | $1.2B+34% | $1.2B+24% | $1B+2% |
| $2.06+10% | $2.24+28% | $2.35−3% | $2.42+13% | $2.50+21% | $2.40+7% | $2.62+12% | $2.81+16% | $2.49−0% | $3.24+35% | $3.18+21% | $2.88+3% | |
| 359.6M+0% | 359.7M+0% | 359.8M+0% | 359.9M+0% | 360M+0% | 360.1M+0% | 360.2M+0% | 360.4M+0% | 360.4M+0% | 360.3M+0% | 363.2M+1% | 361.3M+0% |
Net income: 12 periods, Q1 FY22 to Q1 FY26: not printed by the filing, worked out from its own lines.
EPS, diluted: 8 periods, Q4 FY08 to Q4 FY25: quarter's net income to common over its shares, to the cent.
Diluted shares: 18 periods, Q4 FY08 to Q4 FY25: share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Estimates
Next earnings report: .
| Quarter | Revenue | Range | EPS | Range | Analysts |
|---|---|---|---|---|---|
| Q3 FY26 | $1.7B | $1.7B to $1.7B | $2.99 | $2.92 to $3.08 | 11 |
| Q4 FY26 | $1.8B | $1.7B to $1.8B | $3.03 | $2.94 to $3.10 | 10 |
| Q1 FY27 | $1.9B | $1.8B to $2B | $3.32 | $3.16 to $3.55 | 8 |
| Q2 FY27 | $1.8B | $1.8B to $1.9B | $3.27 | $3.08 to $3.46 | 4 |
| Q3 FY27 | $1.9B | $1.8B to $1.9B | $3.33 | $3.14 to $3.52 | 3 |
| Q4 FY27 | $1.9B | $1.8B to $2B | $3.37 | $3.18 to $3.57 | 4 |
| Q1 FY28 | $2B | $1.9B to $2.1B | $3.69 | $3.48 to $3.90 | 4 |
| Q2 FY28 | $1.9B | $1.9B to $2B | $3.54 | $3.34 to $3.75 | 5 |
Peers
Companies in Financial - Data & Stock Exchanges nearest CME's size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| CMECME | $109.9B | 25.9× | 26.2× | 24.5× | 16.2× | +5% | 63.9% |
| ICEIntercontinental Exchange | $91.4B | 23.0× | 25.9× | 19.6× | 6.8× | +7% | 30.1% |
| SPGIS&P Global | $132.8B | 27.4× | 32.8× | 23.9× | 8.2× | +10% | 30.5% |
| MCOMoody's | $83.7B | 30.7× | 34.4× | 27.2× | 10.3× | +12% | 34.3% |
| NDAQNasdaq | $57.3B | 29.9× | 27.9× | 23.5× | 6.6× | +8% | 22.5% |
| MSCIMSCI | $44.8B | 33.7× | 40.1× | 29.2× | 13.4× | +12% | 40.7% |
| COINCoinbase Global | $43.4B | n/m | 34.6× | 217× | 6.9× | −10% | −15.7% |
| CBOECboe Global Markets | $35.6B | 26.5× | 28.5× | 23.8× | 7.0× | +12% | 26.7% |
| TRUTransUnion | $15.6B | 21.5× | 45.7× | n/m | 3.2× | +12% | 15.1% |
| Peer median | $51B | 27.4× | 33.6× | 23.9× | 7.0× | +11% | 28.4% |
Investors who own it
Investors we follow who held CME at the end of Jun 30, 2026, from their 13F filings.
- Seth KlarmanBaupost Group2.5% of portfolionew
- Andreas HalvorsenViking Global Investors0.1% of portfolionew
- Tom GaynerMarkel Group0.1% of portfolio
- Ron BaronBaron Capital0.0% of portfoliotrimmed
More on CME
Each number over time
- PE ratio
- Forward PE
- Price to sales ratio
- EV/EBIT
- Price to free cash flow
- Price to book ratio
- Dividend yield
- Market cap
- Revenue
- EPS
- Free cash flow
- Profit margin
- Shares outstanding
Where it ranks
- #1of 512Financial stocks with the highest profit margins
- #1of 11Financial data and exchange stocks with the highest profit margins
- #4of 10Financial data and exchange stocks with the lowest PE ratio
- #6of 11Financial data and exchange stocks with the lowest EV/EBIT
- #10of 11Financial data and exchange stocks with the fastest revenue growth
- #10of 10Financial data and exchange stocks with the fastest earnings growth
Its groups
About
- Industry
- Financial - Data & Stock Exchanges
- Sector
- Financial Services
Valuation data, not investment advice. Prices as of .